Arrowhead Pharmaceuticals Inc (ARWR)
28.56
-0.14
(-0.49%)
USD |
NASDAQ |
Mar 28, 16:00
28.60
+0.04
(+0.14%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Market Cap: 3.538B for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 28, 2024 | 3.538B |
March 27, 2024 | 3.556B |
March 26, 2024 | 3.449B |
March 25, 2024 | 3.455B |
March 22, 2024 | 3.371B |
March 21, 2024 | 3.498B |
March 20, 2024 | 3.489B |
March 19, 2024 | 3.441B |
March 18, 2024 | 3.486B |
March 15, 2024 | 3.504B |
March 14, 2024 | 3.397B |
March 13, 2024 | 3.542B |
March 12, 2024 | 3.537B |
March 11, 2024 | 3.643B |
March 08, 2024 | 4.144B |
March 07, 2024 | 4.113B |
March 06, 2024 | 4.386B |
March 05, 2024 | 4.222B |
March 04, 2024 | 4.350B |
March 01, 2024 | 4.470B |
February 29, 2024 | 3.977B |
February 28, 2024 | 4.212B |
February 27, 2024 | 3.861B |
February 26, 2024 | 3.778B |
February 23, 2024 | 3.915B |
Date | Value |
---|---|
February 22, 2024 | 3.742B |
February 21, 2024 | 3.615B |
February 20, 2024 | 3.620B |
February 16, 2024 | 3.652B |
February 15, 2024 | 3.664B |
February 14, 2024 | 3.671B |
February 13, 2024 | 3.707B |
February 12, 2024 | 3.997B |
February 09, 2024 | 4.034B |
February 08, 2024 | 3.822B |
February 07, 2024 | 3.921B |
February 06, 2024 | 4.113B |
February 05, 2024 | 3.967B |
February 02, 2024 | 3.960B |
February 01, 2024 | 3.988B |
January 31, 2024 | 3.977B |
January 30, 2024 | 4.088B |
January 29, 2024 | 4.260B |
January 26, 2024 | 4.056B |
January 25, 2024 | 4.139B |
January 24, 2024 | 4.063B |
January 23, 2024 | 4.246B |
January 22, 2024 | 4.110B |
January 19, 2024 | 4.180B |
January 18, 2024 | 4.104B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.650B
Minimum
May 01 2019
9.401B
Maximum
Jun 25 2021
4.610B
Average
3.988B
Median
Feb 01 2024
Market Cap Benchmarks
Madrigal Pharmaceuticals Inc | 5.313B |
Viking Therapeutics Inc | 8.233B |
Akero Therapeutics Inc | 1.740B |
89bio Inc | 1.086B |
Sagimet Biosciences Inc | 172.34M |
Market Cap Related Metrics
PS Ratio | 16.88 |
PEG Ratio | -0.1166 |
Price to Book Value | 22.06 |
Price | 28.56 |
Earnings Yield | -9.70% |
PEGY Ratio | -0.1166 |